Beta Bionics (BBNX) News Today $18.68 -0.29 (-1.53%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Stephen Feider Sells 4,413 Shares of Beta Bionics (NASDAQ:BBNX) StockAugust 27 at 7:20 AM | insidertrades.comWellington Management Group LLP Makes New Investment in Beta Bionics, Inc. $BBNXAugust 26 at 4:15 AM | marketbeat.comSands Capital Ventures LLC Acquires Shares of 3,103,782 Beta Bionics, Inc. $BBNXAugust 23, 2025 | marketbeat.comStephen Feider Sells 5,587 Shares of Beta Bionics (NASDAQ:BBNX) StockAugust 21, 2025 | insidertrades.comBeta Bionics, Inc. to Present at Upcoming Healthcare Investor Conferences in September 2025August 21, 2025 | quiverquant.comQBeta Bionics Announces Participation at Upcoming Investor ConferencesAugust 21, 2025 | globenewswire.comLord Abbett & CO. LLC Purchases New Stake in Beta Bionics, Inc. (NASDAQ:BBNX)August 19, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 19, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from AnalystsAugust 18, 2025 | americanbankingnews.comBeta Bionics (NASDAQ:BBNX) Stock Price Up 4.5% - What's Next?August 16, 2025 | marketbeat.comTD Asset Management Inc Purchases Shares of 39,876 Beta Bionics, Inc. (NASDAQ:BBNX)August 5, 2025 | marketbeat.comBank of New York Mellon Corp Takes $316,000 Position in Beta Bionics, Inc. (NASDAQ:BBNX)August 5, 2025 | marketbeat.comQ3 EPS Estimates for Beta Bionics Lowered by Leerink PartnrsAugust 2, 2025 | marketbeat.comBeta Bionics Reports Record Growth in Earnings CallAugust 1, 2025 | msn.comTruist Financial Increases Beta Bionics (NASDAQ:BBNX) Price Target to $21.00July 31, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Expected to Rise, Robert W. Baird Analyst SaysJuly 31, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Sees Large Volume Increase After Better-Than-Expected EarningsJuly 31, 2025 | marketbeat.comBeta Bionics, Inc. (BBNX) Q2 2025 Earnings Call TranscriptJuly 31, 2025 | seekingalpha.comBeta Bionics, Inc. 2025 Q2 - Results - Earnings Call PresentationJuly 31, 2025 | seekingalpha.comBeta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceJuly 31, 2025 | finanznachrichten.deBeta Bionics (BBNX) Q2 Revenue Soars 54%July 31, 2025 | theglobeandmail.comBeta Bionics (NASDAQ:BBNX) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPSJuly 30, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 5.9% - Here's What HappenedJuly 29, 2025 | marketbeat.comBeta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceJuly 29, 2025 | globenewswire.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from AnalystsJuly 24, 2025 | marketbeat.comJennison Associates LLC Purchases New Position in Beta Bionics, Inc. (NASDAQ:BBNX)July 22, 2025 | marketbeat.comBeta Bionics, Inc.'s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX)July 22, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Up 6.5% - Should You Buy?July 19, 2025 | marketbeat.comValues First Advisors Inc. Takes $457,000 Position in Beta Bionics, Inc. (NASDAQ:BBNX)July 8, 2025 | marketbeat.comBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - MorningstarJuly 4, 2025 | morningstar.comMBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - Seeking AlphaJuly 4, 2025 | seekingalpha.comAbbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic PancreasJuly 4, 2025 | msn.comBeta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025July 2, 2025 | globenewswire.comBeta Bionics, Inc. (BBNX) Income Statement - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 7.7% - Time to Sell?July 1, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by AnalystsJune 29, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 6.8% - Time to Sell?June 23, 2025 | marketbeat.comEvanson Asset Management LLC Takes $475,000 Position in Beta Bionics, Inc. (NASDAQ:BBNX)June 20, 2025 | marketbeat.comBeta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone SensorJune 19, 2025 | globenewswire.comBeta Bionics stock initiated with Buy rating at Truist SecuritiesJune 17, 2025 | investing.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 5.4% - Here's What HappenedJune 17, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Now Covered by Truist FinancialJune 16, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Up 4.7% - What's Next?June 12, 2025 | marketbeat.comLake Street Capital Begins Coverage on Beta Bionics (NASDAQ:BBNX)June 12, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Gap Up - Should You Buy?June 11, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Trading Down 4.8% - Time to Sell?June 6, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Insider Mark Hopman Sells 868 SharesJune 5, 2025 | marketbeat.comSteven Jon Russell Sells 1,039 Shares of Beta Bionics, Inc. (NASDAQ:BBNX) StockJune 5, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Insider Sells $19,947.35 in StockJune 5, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) CFO Sells $26,781.33 in StockJune 5, 2025 | marketbeat.com Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBNX Media Mentions By Week BBNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBNX News Sentiment▼0.510.99▲Average Medical News Sentiment BBNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBNX Articles This Week▼53▲BBNX Articles Average Week Get the Latest News and Ratings for BBNX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Beta Bionics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Liquidia Technologies News Today PROCEPT BioRobotics News Today LeMaitre Vascular News Today Artivion News Today National Vision News Today Enovis News Today CONMED News Today NovoCure News Today SS Innovations International News Today BioLife Solutions News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBNX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access